The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Appointment of CFO

1 Oct 2019 07:00

RNS Number : 2181O
Manolete Partners PLC
01 October 2019
 

1 October 2019

 

Manolete Partners Plc

("Manolete" or the "Company")

Appointment of CFO

Manolete (AIM:MANO), the leading UK-listed insolvency litigation financing company, announces that Patrick Lineen has decided to retire at the end of December 2019, following the successful IPO of the Company last year. Patrick will step down as Chief Financial Officer on 7 October 2019 when he will be replaced as CFO by Mark Wrenford Tavener. Patrick will remain on the Board until 27 November 2019 and will then retire at the end of the year to ensure an orderly and smooth handover.

Mr Tavener previously worked in RSM's corporate finance department. Prior to RSM, Mr Tavener held roles at IPSX, Deloitte, T-Mobile and PwC.

Steven Cooklin, Chief Executive Officer at Manolete commented:

"We are grateful to Patrick for assisting us through the IPO process and a successful first year as a listed company. We are pleased to welcome Mark to the team at this excting new growth phase of the business.''

 

AIM disclosures

Mark Wrenford Tavener is 49 years old and is joining the Board with effect from 7 October 2019. During the last five years immediately preceding the date of this announcement, Mark Wrenford Tavener held the following directorships:

Previous

IPSX UK Limited

Current

None

There are no further matters to be disclosed pursuant to paragraph (g) of schedule 2 of the AIM Rules.

 

For further information please contact:

Manolete Partners

Steven Cooklin (Chief Executive Officer) via Instinctif Partners

 

Peel Hunt (NOMAD and Sole Broker) +44 (0)20 7418 8900

Guy Wiehahn

Rishi Shah

 

Instinctif Partners +44 (0)20 7457 2020

Catherine Wickman

Katie Bairsto

Lewis Hill

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEBLFXKKFZBBZ

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.